XRAY DENTSPLY SIRONA Inc. - Common Stock

NAS · US · Healthcare · Medical Instruments & Supplies · dentsplysirona.com

8.495USD-2.02%Mkt Cap: 1.73B $P/E: —Today

DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide. It operates through…

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc. - Common Stock

$140.43BUSDP/E 44.8

EssilorLuxottica Société anonyme

$72.05BUSDP/E 27.0

BDX

Becton, Dickinson and Company Common Stock

$48.16BUSDP/E 30.5

MDLN

Medline Inc. - Class A common stock

$47.91BUSDP/E 44.5

RMD

ResMed Inc. Common Stock

Alcon Inc. Ordinary Shares

$30.82BUSDP/E 48.7

WST

West Pharmaceutical Services, Inc. Common Stock

$25.69BUSDP/E 46.8

DIM

Sartorius Stedim Biotech S.A.

$22.21BUSDP/E 69.8

SRT3

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

$15.16BUSDP/E 71.4

SOLV

Solventum Corporation Common Stock

$14.95BUSDP/E 10.7

BAX

Baxter International Inc. Common Stock

$12.14BUSD

COO

The Cooper Companies, Inc. - Common Stock

$10.82BUSDP/E 19.6

AVTR

Avantor, Inc. Common Stock

$10.38BUSD

COO

The Cooper Companies, Inc.

$10.29BUSDP/E 18.6

RGEN

Repligen Corporation - Common Stock

$10.25BUSDP/E 248.9

ALGN

Align Technology, Inc. - Common Stock

$10.21BUSDP/E 25.0

ATR

AptarGroup, Inc. Common Stock

$7.62BUSDP/E 21.6

Key Statistics

Company

Market Cap1.73B USD

Enterprise Value3.82B USD

Revenue (TTM)3.64B USD

Gross Profit1.84B USD

Net Income (TTM)-598.00M USD

Revenue/Share18.24 USD

Last Price8.495 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees14.0K

CountryUS

SectorHealthcare

IndustryMedical Instruments & Supplies

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)5.75

PEG0.56

EV/EBITDA7.26

EV/Revenue1.05

P/S0.47

P/B1.32

EPS (TTM)-2.73

EPS (Forward)1.51

52W Range

8.5850% of range14.76

52W High14.76 USD

52W Low8.585 USD

Profitability

Gross Margin50.00%

Oper. Margin9.24%

EBITDA Margin14.44%

Profit Margin-16.25%

ROE-44.66%

ROA-11.01%

Growth

Revenue Growth-4.10%

Earnings Growth—

Cash Flow & Leverage

Operating CF235.00M USD

CapEx (TTM)131.00M USD

FCF Margin3.89%

FCF Yield8.19%

Net Debt2.09B USD

Net Debt/EBITDA3.97

Balance Sheet

Debt/Equity1.84

Current Ratio1.63

Quick Ratio0.72

Book Value/Sh6.58 USD

Cash/Share1.20 USD

Dividends

Fwd Div Rate0.00 USD

Trail. Div Rate0.32 USD

Div. Yield0.00%

5Y Avg Yield1.81%

Payout Ratio29.56%

Ex-Div DateDec 26, 2025

Pay DateJan 9, 2026

Splits

Last Split2:1

Split DateJul 18, 2006

Analyst Consensus

Rating2.7 (Hold)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)13.73 USD

Upside (mean)+61.7%

Target Range10.00 USD – 17.00 USD

10.00+61.7% to mean17.00

# Analysts15

Ownership

Shares Out.199.35M

Float187.87M

Insiders0.65%

Institutions117.65%

Short Interest

Short Ratio7.0d

Short % Float13.76%

Short % Out.12.33%

Shares Short24.59M

Short (prev mo.)19.68M

Technical

SMA 5011.13 (-23.7%)

SMA 20011.61 (-26.8%)

Beta0.85

S&P 52W Chg14.58%

Avg Vol (30d)4.25M

Avg Vol (10d)5.23M

Technical Indicators

RSI (14)23.9

MACD-0.7489

MACD Signal-0.6572

MACD Hist.-0.0917

BB Upper11.84 USD

BB Middle10.04 USD

BB Lower8.242 USD

BB Width35.81%

ATR (14)0.4274 USD

Vol Ratio (20d)1.32x